79 related articles for article (PubMed ID: 15185315)
1. DDB treatment of patients with chronic hepatitis.
Huber R; Hockenjos B; Blum HE
Hepatology; 2004 Jun; 39(6):1732-3. PubMed ID: 15185315
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
3. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
4. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
[TBL] [Abstract][Full Text] [Related]
6. [Effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2, 2'-dicarboxylate (DDB) on several phenotypes of Bel-7402 hepatocarcinoma cell line and its mechanism].
Liu ZY; Cui Q; Liu GT
Yao Xue Xue Bao; 1996; 31(2):101-6. PubMed ID: 8762469
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
[TBL] [Abstract][Full Text] [Related]
8. Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.
Huber R; Futter I; Lüdtke R
Eur J Med Res; 2005 Feb; 10(2):68-70. PubMed ID: 15817425
[TBL] [Abstract][Full Text] [Related]
9. Artichoke leave extract for chronic hepatitis C - a pilot study.
Huber R; Müller M; Naumann J; Schenk T; Lüdtke R
Phytomedicine; 2009 Sep; 16(9):801-4. PubMed ID: 19427774
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
[TBL] [Abstract][Full Text] [Related]
11. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
12. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
Rino Y; Tarao K; Morinaga S; Ohkawa S; Miyakawa K; Hirokawa S; Masaki T; Tarao N; Yukawa N; Saeki H; Takanashi Y; Imada T
Anticancer Res; 2006; 26(3B):2221-6. PubMed ID: 16821591
[TBL] [Abstract][Full Text] [Related]
13. [Comparison on the efficacy and safety of biphenyl dimethyl dicarboxylate and ursodeoxycholic acid in patients with abnormal alanine aminotransferase: multicenter, double-blinded, randomized, active-controlled clinical trial].
Lee SH; Cheon GJ; Kim HS; Kim YD; Kim SG; Kim YS; Jeong SW; Jang JY; Kim BS
Korean J Gastroenterol; 2014 Jul; 64(1):31-9. PubMed ID: 25073669
[TBL] [Abstract][Full Text] [Related]
14. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
Yu ML; Dai CY; Lee LP; Hou NJ; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
Liver Int; 2006 Dec; 26(10):1187-95. PubMed ID: 17105583
[TBL] [Abstract][Full Text] [Related]
15. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
16. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
[TBL] [Abstract][Full Text] [Related]
17. Does Silybum marianum play a role in the treatment of chronic hepatitis C?
Torres M; Rodríguez-Serrano F; Rosario DJ; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):69-74. PubMed ID: 16929590
[TBL] [Abstract][Full Text] [Related]
18. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage].
You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Hennessy T; Williams J; Livingston S; Gretch D
Liver Int; 2006 Aug; 26(6):643-9. PubMed ID: 16842319
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of chronic hepatitis B based on histological grade and stage.
Park BK; Park YN; Ahn SH; Lee KS; Chon CY; Moon YM; Park C; Han KH
J Gastroenterol Hepatol; 2007 Mar; 22(3):383-8. PubMed ID: 17295771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
